Hemophilia Type C
Links shared publicly online about this topic
Hemophilia, Type B: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: Hemophilia B is an inherited, X-linked, recessive disorder resulting in deficiency of functional plasma coagulation factor IX. Spontaneous mutation and acquired immunologic processes can result in this disorder as well. Morbidity and death are primarily the ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 27, 2010 at 4:09 am By:
Hemophilia B is an inherited disorder resulting in deficiency of functional plasma coagulation factor IX. http://bit.ly/9cFp1i
Hemophilia, Type A: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: Hemophilia A is an inherited, X-linked, recessive disorder resulting in deficiency of functional plasma coagulation factor VIII. Significant rates of spontaneous mutation and acquired immunologic processes can result in this disorder as well. Morbidity and death ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 27, 2010 at 4:12 am By:
Hemophilia A is an inherited disorder resulting in deficiency of functional plasma coagulation factor VIII. http://bit.ly/985sDR
Oncology Medical News about Hemophilia A
mdlinx.com — “Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates” View full resource at mdlinx.com
Most Recently Shared on June 30, 2010 at 4:09 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived o... http://bit.ly/c7H6aD #oncology
Researchers develop new animal model for studying hemophilia A
news-medical.net — “Researchers at Yale School of Medicine have developed a new animal model for studying hemophilia A, with the goal of eventually treating people with the disorder.” View full resource at news-medical.net
Most Recently Shared on September 4, 2010 at 3:45 am By:
Researchers develop new animal model for studying hemophilia A: Researchers at Yale School of Medicine have develo... http://bit.ly/c8B99S
Hemophilia Drug Used Off-Label Raises Clot Risk
health.yahoo.net — “WEDNESDAY, Nov. 3 (HealthDay News) -- A drug approved to help staunch bleeding in people with hemophilia raises the risk of heart attacks and stroke when it's used to stop life-threatening bleeding due to other conditions, such as trauma or surgery, a new study finds.” View full resource at health.yahoo.net
Most Recently Shared on November 4, 2010 at 11:34 am By:
allergydropz Surgeon, ENT Doctor, Physician, and Doctor
Yahoo health: Hemophilia Drug Used Off-Label Raises Clot Risk http://bit.ly/9ARovV Full http://bit.ly/cFp9zB
Hemophilia B - Single Gene Therapy Treatment Offers Significant Improvement
medicalnewstoday.com — “Patients with hemophilia B experienced considerable improvements and fewer injections with clotting factor to reduce bleeding after receiving just one treatment with gene therapy, researchers from” View full resource at medicalnewstoday.com
Most Recently Shared on December 10, 2011 at 8:05 pm By:
Hemophilia B - Single Gene Therapy Treatment Offers Significant Improvement http://t.co/1RVC3T8U #blood #hematology
CDC Features - WORLD HEMOPHILIA DAY, 4/17/11 - Hemophilia: Signs, Symptoms and Treatment - Digg
digg.com — “April 17th is World Hemophilia Day. Learn how to recognize the hemophilia symptoms and where to receive comprehensive treatment.” View full resource at digg.com
Most Recently Shared on April 15, 2011 at 5:56 pm By:
SNAPPIN' MINISTRIES Patient Advocate
CDC Features - WORLD HEMOPHILIA DAY, 4/17/11 - #Hemophilia: Signs, Symptoms and Treatment http://t.co/Kb6FKaC via @Digg
MedPro Rx, Inc. Sponsored Virginia Hemophilia Foundation Annual Meeting - PR.com
pr.com — “MedPro Rx, Inc. Sponsored Virginia Hemophilia Foundation Annual Meeting - on PR.com” View full resource at pr.com
Most Recently Shared on June 18, 2010 at 9:20 am By:
MedPro Rx, Inc. Sponsored Virginia Hemophilia Foundation Annual Meeting http://bit.ly/c89zkP
ASH: Analog Useful in Hemophilia With Inhibitors (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “ORLANDO (MedPage Today) -- An experimental agent that closely mimics normal human clotting appears to rapidly curtail bleeding episodes in patients with hemophilia that is complicated by inhibitors against clotting factors, a researcher said here.” View full resource at qualitypointtech.net
Most Recently Shared on December 8, 2010 at 5:03 pm By:
ASH: Analog Useful in Hemophilia With Inhibitors (CME/CE): ORLANDO (MedPage Today) -- An experimental agent that c... http://bit.ly/fPWtua
Swedish Orphan Biovitrum's Hemophilia A Therapy Receives European Commission Orphan Drug Designation - QualityPoint Technologies
qualitypointtech.net — “Swedish Orphan Biovitrum (STO:SOBI) announced that the European Commission has granted orphan drug designation to its long-lasting, fully-recombinant Factor FVIII Fc fusion protein (rFVIIIFc), which is partnered with Biogen Idec (NASDAQ: BIIB). It was recently announced that the companies plan to advance the rFVIIIFc program into a registrational clinical trial in patients with severe hemophilia A. Treatment of severe hemophilia A requires frequent infusions, creating a significant burden for in” View full resource at qualitypointtech.net
Most Recently Shared on September 26, 2010 at 6:00 am By:
Swedish Orphan Biovitrum's Hemophilia A Therapy Receives European Commission Orphan Drug Designation: Swedish Orp... http://bit.ly/9loqlC
Teacher--™s toddler inspires students to raise funds for hemophilia research » Local News » MuskogeePhoenix.com, Muskogee, OK
muskogeephoenix.com — “Despite living with bumps, bruises and shots three times a week, 2-year-old Cameron Voyles is as active as any other toddler, his mother said. Camero” View full resource at muskogeephoenix.com
Most Recently Shared on January 7, 2011 at 3:30 pm By:
SNAPPIN' MINISTRIES Patient Advocate
Teacher’s toddler inspires students to raise funds for #hemophilia research http://shar.es/X9C0L via @WIHemophilia
Bayer HealthCare Provides Nearly $2.5 Million to Advance Hemophilia Research and Patient Care - PR Newswire - sacbee.com
sacbee.com — “/PRNewswire/ -- Bayer HealthCare today announced the 2011 recipients of the Bayer Hemophilia Awards Program (BHAP). This year, the company has awarded nearly $2.5 million in funding to 18 recipients from 12 countries, including the U.S. BHAP, the largest program of its kind for the hemophilia community, was created to help improve the understanding and treatment of hemophilia and related bleeding disorders. The program also seeks to reduce the disease's impact on individuals an” View full resource at sacbee.com
Most Recently Shared on July 29, 2011 at 9:07 am By:
Bayer HealthCare Provides Nearly $2.5 Million to Advance Hemophilia Research ...: By Bayer HealthCare WAYNE, NJ,... http://bit.ly/phlHU9
Factor XI Deficiency: eMedicine Hematology
emedicine.medscape.com — “Overview: Factor XI (FXI) deficiency is an autosomal disorder that may be associated with bleeding. Other terms for this disorder include plasma thromboplastin antecedent (PTA) deficiency, Rosenthal syndrome, and hemophilia C. Rosenthal first described this bleeding disorder ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 9:25 pm By:
Factor XI (FXI) deficiency is an autosomal disorder that may be associated with bleeding. Learn more about factor XI. http://bit.ly/bQKYGS
::: Blood CME Center :::
bloodcmecenter.com — “Blood CME Center is a free educational initiative developed by experts in the fields of perioperative hemostasis, hematologic malignancies, and hemophilia and other bleeding disorders. Blood CME Center provides free continuing medical education (CME) featuring Web-based learning, such as podcasts and slide presentations. Visit our Web site to register and access free educational materials.” View full resource at bloodcmecenter.com
Most Recently Shared on August 22, 2011 at 9:04 pm By:
Blood CME Center Health Organization
The Aging #Hemophilia Patient: Comorbidities and Management Issues - Online CME with Dr. Aledort http://t.co/BICAJ4h
Relationship of Cystatin C and Hypertension in Type 1 Diabetes
hcplive.com — “Researchers have found a link between serum cystatin C and the incidence of hypertension in patients with type 1 diabetes mellitus.” View full resource at hcplive.com
Most Recently Shared on January 5, 2011 at 9:04 pm By:
#CME articles on #HCPLIve! Latest is on relationship of cystatin C and #hypertension in type 1 #diabetes http://hcp.lv/dHjWZc
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
